The Diatrizoate Meglumine Injection, cataloged under National Stock Number 6505-01-163-1283, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ge Healthcare Inc Dba Ge Healthcare. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 6 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 2 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-163-1283 |
| Primary Part Number | NDC00407-0749-20 |
| Item Name | Diatrizoate Meglumine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Ge Healthcare Inc Dba Ge Healthcare |
| Status | ACTIVE |
| Primary Container Content Quantity | 150.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00407-0749-20 PRIMARY | Ge Healthcare Inc Dba Ge Healthcare (USA) |
| Reference | Meaning |
|---|---|
| NDC00024-0749-01 | 5/9 Secondary reference Sanofi-Synthelabo, Inc |
| NDC00003-0696-70 | 5/9 Secondary reference Bristol-Myers Squibb Company Dba Bristol-Myers Squibb |
| H-588 | 5/9 Secondary reference Sanofi-Synthelabo, Inc |
| H-585 | 5/9 Secondary reference Sanofi-Synthelabo, Inc |
| NDC00024-0749-10 | 5/9 Secondary reference Sanofi-Synthelabo, Inc |
| HYPAQUE MEGLUMINE | 5/9 Secondary reference Sanofi-Synthelabo, Inc |
NSN 6505-01-163-1283 is a Diatrizoate Meglumine Injection, manufactured by Ge Healthcare Inc Dba Ge Healthcare, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-163-1283 has 1 manufacturer part number on file: NDC00407-0749-20 (Ge Healthcare Inc Dba Ge Healthcare).
2 possible matches (shared part number, not a government interchangeability claim): 5330-01-274-6100, 6685-01-300-9090. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00407-0749-20: Primary Container Content Quantity: 150.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: 150 ML IN OVERSIZE 200 ML BOTTLE WITH SOLUTION ADMINISTRATION SET; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.